| Welcure Drugs & Pharmaceuticals Ltd | Industry : (Trading) | |
|---|---|---|
|
BSE Code : 524661 |
NSE Symbol : - |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE331C01025 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 0.79 |
Market Cap(₹Cr) : 32.13 |
Face Value(₹) : 1.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 0.00 | 0.00 | 65.62 | 299.91 | 21.21 | 0.88 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 0.00 | 0.00 | 65.62 | 299.91 | 21.21 | 0.88 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.00 | 1.46 | 0.00 | 0.00 | 1.91 | 0.00 |
| Total Income | 0.00 | 1.46 | 65.62 | 299.91 | 23.12 | 0.88 |
| Total Expenditure | 49.86 | 0.03 | 54.25 | 268.77 | 20.58 | 0.79 |
| PBIDT | -49.86 | 1.43 | 11.37 | 31.14 | 2.55 | 0.09 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | -49.86 | 1.43 | 11.37 | 31.14 | 2.55 | 0.09 |
| Depreciation | 0.00 | 0.01 | 0.00 | 0.00 | 0.01 | 0.00 |
| Tax | 0.00 | 0.36 | 2.86 | 7.84 | 0.00 | 0.05 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | -49.86 | 1.07 | 8.50 | 23.30 | 2.54 | 0.04 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -49.86 | 1.07 | 8.50 | 23.30 | 2.54 | 0.04 |
| EPS (Unit Curr.) | -0.40 | 0.13 | 0.76 | 2.07 | 0.33 | 0.04 |
| EPS (Adj) (Unit Curr.) | -0.40 | 0.13 | 0.07 | 0.19 | 0.03 | 0.00 |
| Calculated EPS (Unit Curr.) | -0.40 | 0.45 | 0.76 | 2.07 | 0.23 | 0.03 |
| Calculated EPS (Adj) (Unit Curr.) | -0.40 | 0.45 | 0.07 | 0.19 | 0.02 | 0.00 |
| Calculated EPS (Ann.) (Unit Curr.) | -1.61 | 1.81 | 3.03 | 8.29 | 0.90 | 0.12 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -1.61 | 1.81 | 0.28 | 0.76 | 0.08 | 0.01 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 123.59 | 23.59 | 112.44 | 112.36 | 112.44 | 13.44 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 0.00 | 0.00 | 17.33 | 10.38 | 12.02 | 10.23 |
| PBDTM(%) | 0.00 | 0.00 | 17.33 | 10.38 | 12.02 | 10.23 |
| PATM(%) | 0.00 | 0.00 | 12.95 | 7.77 | 11.98 | 4.55 |
